Hoth's Management Team And Scientific Advisory Board Report Wrapping Up A Busy 2021 Of Clinical Research
SponsoredHoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results - Reduce Amyloid β in Alzheimer's Disease
SponsoredHoth Therapeutics Reports Orphan Designation Application to Treat Mastocytosis, To Receive Exclusive Rights and Cost Benefits on Approval
SponsoredHoth Therapeutics Reports Finishing Up a Busy Year of Research Across its Portfolio of Drug Candidates
Sponsored